Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.
| FactSnippet No. 1,132,628 |
25 Facts About Roche Diagnostics
2.
Roche Diagnostics is the fifth largest pharmaceutical company in the world by revenue, and the leading provider of cancer treatments globally.
| FactSnippet No. 1,132,629 |
3.
Roche Diagnostics is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
| FactSnippet No. 1,132,630 |
4.
Hoffmann-La Roche Diagnostics is a full member of the European Federation of Pharmaceutical Industries and Associations .
| FactSnippet No. 1,132,631 |
5.
That year Hoffmann-La Roche Diagnostics then merged it with all of its laboratories, and incorporated the merged company as Roche Diagnostics Biomedical Laboratories, Inc in Burlington.
| FactSnippet No. 1,132,632 |
6.
Roche Diagnostics acquired Syntex in 1994 and Chugai Pharmaceuticals in 2002.
| FactSnippet No. 1,132,633 |
7.
Roche Diagnostics is the only drug company authorized to manufacture the drug, which was discovered by Gilead Sciences.
| FactSnippet No. 1,132,634 |
8.
On 20 October 2005 Hoffmann-La Roche Diagnostics decided to license other companies to manufacture Oseltamivir.
| FactSnippet No. 1,132,635 |
9.
Also in 2005 Roche Diagnostics acquired the Swiss company GlycArt Biotechnology in order to acquire technology to afucosylate antibodies; one of its products in development was obinutuzumab, which gained FDA approval in November 2013 for the treatment of chronic lymphocytic leukemia.
| FactSnippet No. 1,132,636 |
10.
On 12 March 2009 Roche Diagnostics agreed to fully acquire Genentech, in which it had held a majority stake since 1990, after eight months of negotiations.
| FactSnippet No. 1,132,637 |
11.
Roche Diagnostics began vacating the NJ site in 2012, and sold it off in 2016.
| FactSnippet No. 1,132,638 |
12.
In March 2011, Roche Diagnostics acquired PVT Probenverteiltechnik GmbH for up to €85 million.
| FactSnippet No. 1,132,639 |
13.
In July 2010, Roche Diagnostics acquired mtm laboratories AG for up to 190 million EUR.
| FactSnippet No. 1,132,640 |
14.
In July 2013, Roche Diagnostics acquired blood diagnostics company Constitution Medical Inc for $220 million.
| FactSnippet No. 1,132,641 |
15.
On 7 April 2014, Roche Diagnostics announced its intention to acquire IQuum for up to $450 million, as well as the rights to an experimental drug from Spanish company Oryzon Genomics for $21 million and up to $500 million in milestone payments.
| FactSnippet No. 1,132,642 |
16.
In February 2018, Roche Diagnostics announced it would acquire Flatiron Health, a business specialising in US cancer data analytics, for $1.
| FactSnippet No. 1,132,643 |
17.
In March 2021, Roche announced it would acquire GenMark Diagnostics for $1.
| FactSnippet No. 1,132,644 |
18.
Hoffmann-La Roche Diagnostics family is Switzerland's richest and one of the most secretive families.
| FactSnippet No. 1,132,645 |
19.
Internally, it is organized into five major business areas: Roche Applied Science, Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics and Roche Tissue Diagnostics .
| FactSnippet No. 1,132,646 |
20.
All business areas except Roche Diagnostics Applied Science focus on health care applications, targeting either physicians, hospitals and clinics, or consumers.
| FactSnippet No. 1,132,647 |
21.
Hoffmann-La Roche Diagnostics develops drugs used for cancer treatment, against virus diseases and for treatment of metabolic diseases.
| FactSnippet No. 1,132,648 |
22.
Roche Diagnostics was fined accordingly, but a bungle on the part of the EEC allowed the company to discover that it was Adams who had blown the whistle.
| FactSnippet No. 1,132,649 |
23.
Roche Diagnostics's wife, having learnt that he might face decades in jail, committed suicide.
| FactSnippet No. 1,132,650 |
24.
Hoffmann-La Roche Diagnostics paid $500 million in criminal fines to the United States.
| FactSnippet No. 1,132,651 |
25.
Roche Diagnostics is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of EFPIA and the European Commission.
| FactSnippet No. 1,132,652 |